The genetic background of ankylosing spondylitis

Joint Bone Spine

Volumn 76, Issue 6, 2009, Pages 623-628

  Végvári, Anikó ^a   Szabó, Zoltán ^a   Szántó, Sándor ^a   Glant, Tibor T ^b   Mikecz, Katalin ^b   Szekanecz, Zoltán ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ankylosing spondylitis; Genetics; Genome wide association studies; HLA B27; Linkage studies; Non MHC genes

Indexed keywords

AMINOPEPTIDASE; CYTOCHROME P450 2D6; ENDOPLASMIC RETICULUM ASSOCIATED AMINOPEPTIDASE 1; HLA B27 ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 23 RECEPTOR; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ANKYLOSING SPONDYLITIS; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN GENOME; NONHUMAN; RISK ASSESSMENT; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CHROMOSOME MAPPING; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; LINKAGE (GENETICS); MICE; PROTEOGLYCANS; SPONDYLITIS, ANKYLOSING;

EID: 71249120031     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2009.02.006     Document Type: Short Survey

References (60)

1. van der Linden S.M., van der Heijde D., and Maksymowych W.P. Ankylosing spondylitis. In: Firestein G.S., Budd R.C., Harris Jr. E.D., McInnes I.B., Ruddy S., and Sergent J.S. (Eds). Kelley's textbook of rheumatology. 8th edition II (2008), Saunders-Elsevier, Philadelphia 1169-1190 [Chapter 70]
2. Brionez T.F., and Reveille J.D. The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis. Curr Opin Rheumatol 20 (2008) 384-391
3. Breban M., Miceli-Richard C., Zinovieva E., et al. The genetics of spondyloarthropathies. Joint Bone Spine 73 (2006) 355-362
4. Brown M.A. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 47 (2008) 132-137
5. Said-Nahal R., Miceli-Richard C., Berthelot J.M., et al. The familial form of spondylarthropathy: a clinical study of 115 multiplex families. Arthritis Rheum 43 (2000) 1356-1365
6. van der Linden S.M., Valkenburg H.A., de Jongh B.M., et al. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 27 (1984) 361-368
7. Brown M.A., Kennedy L.G., MacGregor A.J., et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40 (1997) 1823-1828
8. Brown M.A., Pile K.D., Kennedy L.G., et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55 (1996) 268-270
9. Reveille J.D. Major histocompatibility genes and ankylosing spondylitis. Best Pract Res Clin Rheumatol 20 (2006) 601-609
10. Gran J.T., Husby G., Hordvik M., et al. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway. Ann Rheum Dis 44 (1985) 359-367
11. Braun J., Bollow M., Remlinger G., et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41 (1998) 58-67
12. Khan M.A. Update on spondyloarthropathies. Ann Intern Med 136 (2002) 896-907
13. Ebringer A., and Wilson C. HLA molecules, bacteria and autoimmunity. J Med Microbiol 49 (2000) 305-311
14. Carter K.W., Pluzhnikov A., Timms A.E., et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology 48 (2007) 763-771
15. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-683
16. Wellcome Trust Case Control Consortium, The Australo-Anglo-American Spondylitis Consortium. A genome-wide scan of 14,000 non-synonymous coding SNP in 5,500 individuals. Nat Genet 39 (2007) 1329-1336
17. Amor B., Feldmann J.L., Delbarre F., et al. HLA antigen W27 - a genetic link between ankylosing spondylitis and Reiter's syndrome?. N Engl J Med 290 (1974) 572
18. Brewerton D.A., Hart F.D., Nicholls A., et al. Ankylosing spondylitis and HLA-B27. Lancet 1 (1973) 904-907
19. Laval S.H., Timms A., Edwards S., et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 68 (2001) 918-926
20. Miceli-Richard C., Zouali H., Said-Nahal R., et al. Significant linkage to spondylarthropathy on 9q31-34. Hum Mol Genet 13 (2004) 1641-1648
21. Zhang G., Luo J., Bruckel J., et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 50 (2004) 2246-2254
22. Breban M., Hacquard-Bouder C., and Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 4 (2004) 21-40
23. Hildebrand W.H., Turnquist H.R., Prilliman K.R., et al. HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction. Hum Immunol 63 (2002) 248-255
24. Colbert R.A. The immunobiology of HLA-B27: variations on a theme. Curr Mol Med 4 (2004) 21-30
25. Kuon W., Kuhne M., Busch D.H., et al. Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy. J Immunol 173 (2004) 4859-4866
26. Brown M.A., Pile K.D., Kennedy G.L., et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 41 (1998) 588-595
27. Brown M.A., Brophy S., Bradbury L., et al. Identification of major loci controlling clinical manifestations of ankylosing spondylitis. Arthritis Rheum 48 (2003) 2234-2239
28. Krug H.E., Wietgrefe M.M., Ytterberg S.T., et al. Murine progressive ankylosis is not immunologically mediated. J Rheumatol 24 (1997) 115-122
29. Szabo Z., Szanto S., Vegvari A., et al. Genetic control of experimental spondylarthropathy. Arthritis Rheum 52 (2005) 2452-2460
30. Vegvari A., Szabo Z., Szanto S., et al. Two major interacting chromosome loci control disease susceptibility in murine model of spondyloarthropathy. J Immunol 175 (2005) 2475-2483
31. Lander E., and Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 (1995) 241-247
32. Brown M.A. Nonmajor-histocompatibility-complex genetics of ankylosing spondylitis. Best Pract Res Clin Rheumatol 20 (2006) 611-621
33. Jacques C., Gosset M., Berenbaum F., et al. The role of IL1 and IL1-Ra in joint inflammation and cartilage degradation. Vitam Horm 74 (2006) 371-403
34. Szekanecz Z., and Koch A.E. Cytokines. In: Ruddy S., Harris Jr. E.D., Sledge C.B., Budd R.C., and Sergent J.S. (Eds). Kelley's textbook of rheumatology. 6th Edition (2001), W.B. Saunders, Philadelphia 275-290 [Chapter II.20]
35. McGarry F., Neilly J., Anderson N., et al. A polymorphism within the interleukin-1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology 40 (2001) 1359-1364
36. van der Paardt M., Crusius J.B., Garcia-Gonzalez M.A., et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology 41 (2002) 1419-1423
37. Li J., Ge Z., Akey J.M., et al. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis Rheum 50 (2004) 3047-3048
38. Timms A.E., Crane A.M., Sims A.M., et al. The interleukin-1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 75 (2004) 587-595
39. Maksymowych W.P., Rahman P., Reeve J.P., et al. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum 54 (2006) 974-985
40. Wu Z., and Gu J.R. A meta-analysis on interleukin-1 gene cluster polymorphism and genetic susceptibility for ankylosing spondylitis. Zhonghua Yi Xue Za Zhi 87 (2007) 433-437
41. Sims A.M., Timms A.E., Bruges-Armas J., et al. Prospective meta-analysis of IL-1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 67 (2008) 1305-1309
42. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
43. Cargill M., Schrodi S.J., Chang M., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80 (2007) 273-290
44. Faragó B., Magyari L., Safrany E., et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 67 (2008) 248-250
45. Rahman P., Inman G.D., Gladman D.D., et al. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 58 (2008) 1020-1025
46. Rueda B., Orozco G., Raya E., et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67 (2008) 1451-1454
47. Cui X., Rouhani F., Hawari F., et al. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem 278 (2003) 28677-28685
48. Hammer G.E., Kanaseki T., and Shastri N. The final touches make perfect the peptide-MHC class I repertoire. Immunity 26 (2007) 397-406
49. Firat E., Saveanu L., Aichele P., et al. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J Immunol 178 (2007) 2241-2248
50. Brown M.A., Edwards S., Hoyle E., et al. Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 9 (2000) 1563-1566
51. Jaakkola E., Crane A.M., Laiho K., et al. The effect of transforming growth factor β1 gene polymorphisms in ankylosing spondylitis. Rheumatology 43 (2004) 32-38
52. Tsui H.W., Inman R.D., Paterson A.D., et al. ANKH variants associated with ankylosing spondylitis. Arthritis Res Ther 7 (2005) R513-R525
53. Snelgrove T., Lim S., Greenwood C., et al. Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 34 (2007) 368-370
54. van der Paardt M., Crusius J.B., Garcia-Gonzalez M.A., et al. Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms. Ann Rheum Dis 64 (2005) 616-619
55. Timms A.E., Zhang Y., Bradbury L., et al. Investigation on the role of ANKH in ankylosing spondylitis. Arthritis Rheum 48 (2003) 2898-2902
56. Gergely P., Blazsek A., Weiszhar Z., et al. Lack of genetic association of the toll-like receptor 4 (TLR4) Asp299Gly and Thr399Ile polymorphisms with spondyloarthropathies in a Hungarian population. Rheumatology 45 (2006) 1194-1196
57. van der Paardt M., Crusius J.B.A., de Koning M.H.M.T., et al. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 4 (2003) 77-78
58. Glant T.T., Mikecz K., Arzoumanian A., et al. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 30 (1987) 201-212
59. Mikecz K., Glant T.T., and Poole A.R. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 30 (1987) 306-318
60. Pizcueta P., and Luscinskas F.W. Monoclonal antibody blockade of L-selectin inhibits mononuclear leukocyte recruitment to inflammatory sites in vivo. Am J Pathol 145 (1994) 461-469